TransCode Therapeutics (RNAZ) Total Business Assets

transcodetherapeutics.com (RNAZ) - corporate logo

TransCode Therapeutics (RNAZ) focuses on the sustainable production of RNA-based drugs, implementing "green chemistry" principles to minimize energy consumption and ensure the safe disposal of chemicals. Localizing research within the US mitigates political risks and ensures robust patent protection. The share price retrospective, with total assets at 86.04, reflects the impact of oncology therapy breakthroughs, new grants, and acquisition prospects.

TransCode Therapeutics, Inc. (RNAZ) Company Total Assets: for the period 07/04/2022 - 10/26/2026

Summary analytical data breakdowns for transcodetherapeutics.com (RNAZ)

- price and consensus price forecast:
Quote Chart TransCode Therapeutics, Inc.|RNAZ - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization TransCode Therapeutics|RNAZ - Total Company Value
- book capitalization data:
Equity per Share TransCode Therapeutics|RNAZ - Book Capitalization|Market Capitalization to Book Value Ratio transcodetherapeutics.com|RNAZ - Cumulative Company Assets
- debt and liquidity data:
Aggregate Debt to Capital TransCode Therapeutics|RNAZ - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital TransCode Therapeutics, Inc.|RNAZ - Company Aggregate Debts|Debts to Book Capitalization TransCode Therapeutics
Fundamental valuation:TransCode, RNAZ
Finished products of TransCode Therapeutics Inc.

The balance sheet asset dynamics of TransCode Therapeutics (RNAZ), reverse-calculated via ROA, reflect the market consensus regarding the aggregate resources and liabilities of TransCode Therapeutics (RNAZ), where the long-term trend outweighs short-term fluctuations in capital structure. For this "asset-light" biotech company, this metric demonstrates capital management efficiency under a full outsourcing model for RNA therapy clinical trials, minimizing the need for in-house manufacturing capacities.

Analysis of competing companies

Tempus AI, Inc (TEM) - Total Asset Value of Company|Company Total Assets Qiagen (QGEN)|Total Business Assets IONS|Aggregate Company Assets Repligen Corp. RGEN|Total Business Assets Avidity Corp (RNA)|Company Total Assets CRSP (CRISPR Therapeutics AG)|WGS - Company Total Assets|Cumulative Company Assets Ultragenyx RARE|BEAM: Aggregate Business Assets|Aggregate Company Assets Sarepta Therapeutics Inc SRPT|Twist Bioscience Corp (TWST) - Aggregate Asset Value|TXG (10x Genomics, Inc.) - Company Total Assets|Company Total Assets NTLA|Aggregate Company Assets Stoke Therapeutics, Inc. STOK|Total Business Assets BLFS (BioLife Solutions Inc)|Aggregate Company Assets WVE|Company Total Asset Base Maze Therapeutics Corp MAZE|SION: Company Total Assets|PRME: Cumulative Company Assets|Aggregate Company Assets TSHA|uniQure NV (QURE) - Company Assets|Company Total Assets MeiraGTx PLC (MGTX)|Total Business Assets REGENXBIO Corp|Solid Biosciences Inc. - Company Total Assets|Company Assets ocugen.com OCGN|Cumulative Company Assets PacBio|BNTC - Aggregate Asset Value|Cumulative Company Assets Design Pharma DSGN|RCKT - Aggregate Business Assets|Company Total Assets 4D Molecular Therapeutics FDMT|Lexeo Therapeutics, Inc. (LXEO) - Aggregate Asset Value|Company Total Assets KRRO (Korro Bio Inc.)|Company Assets EDIT|Silence Therapeutics Inc. (SLN) - Aggregate Company Assets|Aggregate Asset Value proqr.com (PRQR)|Company Total Assets CDXS (Codexis)|sangamo.com - Company Total Assets|Aggregate Company Assets Nautilus Biotechnology Inc|MGX - Total Asset Value of Company|Company Total Assets DTIL|Company Assets Generation Bio|BOLD (Boundless Bio, Inc.) - Cumulative Company Assets|Company Total Assets Exicure Corp (XCUR)|Cumulative Company Assets Imunon, Inc.|Aggregate Business Assets phiopharma.com (PHIO)|Company Total Assets MBIO|Company Total Asset Base Bionano Genomics Inc. BNGO|APDN: Company Total Assets|BLUE: Cumulative Company Assets|immunoprecise.com - Aggregate Company Assets|OMGA (Omega Therapeutics Inc) - Company Total Asset Base|OMIC - Aggregate Company Assets|Aggregate Asset Value RGLS|Aggregate Company Assets Syros Pharmaceuticals SYRS|Total Business Assets telesisbio.com (TBIO)|Company Total Assets TCON (TRACON Pharmaceuticals, Inc.)|UBX - Company Total Assets